London-based medical research organisation @lifearc.bsky.social has helped launch four projects aimed at identifying the most promising repurposed drug candidates to treat motor neurone disease.

healthcaretoday.com/article/life...

#Healthcare #MND #MotorNeuroneDisease #DrugCandidates

Deep Dive AI

#pharma #AIrevolution #lifesciences #DiscoveryDisrupted #AI #AIrevolution #AIearlyadopters #drugcandidates #patientengagement #HCPs #AIdrivendrugdevelopment #AIreadyworkforce #drugdiscovery #AIdrugdiscovery #AImedicines #biopharma #Spatialomics #personalisedclinicalmedicine
zurl.co/9YdEd

Streamlining Drug Bioavailability Prediction with KNIME’s Low-Code Machine Learning Harnessing Open-Source Tools to Accelerate Early-Stage Drug Development

🚀 Nearly 40% of #drugcandidates fail early due to poor #bioavailability. Hammami Majdi shows how #KNIME and its #ML capabilities predicts it faster—combining molecular descriptors & low-code workflows to cut costly experiments & speed. Check it out!

📌 #READ → medium.com/low-code-for...

Biopharma BD&L: the tsunami is upon us Pharma’s business development and licensing (BD&L) teams are navigating a complex marketplace and traditional approaches aren't working.

As the #biopharma industry navigates an increasingly complex marketplace, traditional approaches to identifying & evaluating potential #drugcandidates are straining.
What led to this tsunami of pressure and how can BD&L teams weather these challenges?
Learn more in this post:
bit.ly/4lFhcch #bdandl

2/5 – Dual target permeabilizers:
We tested three promising #DrugCandidates – POL7306, Tridecaptin M152-P3, and SCH79797 – against tough #ESKAPE pathogens like E. coli, K. pneumoniae, A. baumannii, and P. aeruginosa. The results? #ResistanceEvolution was significantly limited.